Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MCK · against 588 other Healthcare companies listed in US-listed
Ranked #119 of 589 · scores higher than 79% of peers
Bars: peers in each 10-point band of the valuation score43 peers with a valuation score of 60–69, including MCK · Click a bar to see the companies
Mainly thanks to its free cash flow yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | MCK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 3.5% | -4.3% | 83% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 5.3% | -0.8% | 72% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 4.9% | -2.2% | 84% | 20% | |
| Book yieldHigher is better · 587 reported | -3.4% | 24.9% | 7% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 247M USD | 98 | 80 | |
| 2 | 622M USD | 96 | 97 | |
| 2 | 441M USD | 96 | 81 | |
| 2 | 336M USD | 96 | 57 | |
| 2 | 817M USD | 96 | 69 | |
| 119 | 1.3B USD | 61 | 67 | |
| 119 | 11.0B USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 61 |
| 64 |
| 119 | 43.4B USD | 61 | 45 |
| 119 | 5.2B USD | 61 | 64 |
| 119 | 124.7B USD | 61 | 56 |
| 125 | 21.6B USD | 60 | 66 |
| 125 | 258.7B USD | 60 | 55 |
| 125 | 1.2B USD | 60 | 43 |
| 125 | 4.3B USD | 60 | 54 |